Anemia, Sickle Cell
Rare Disease·MeSH: Anemia, Sickle Cell
Prevalence
30.0 / 100K
1 drug in development·1 company·1 clinical trial
Drug Pipeline by Phase
Phase 4(1)
| Drug | Company |
|---|---|
| bms-986470 | BRISTOL MYERS SQUIBB CO (BMY) |
Frequently asked questions
How many drugs are in development for Anemia, Sickle Cell?
BioSniper tracks 1 drug in development for Anemia, Sickle Cell across 1 company.
How many clinical trials target Anemia, Sickle Cell?
There are 1 clinical trial targeting Anemia, Sickle Cell tracked by BioSniper.
What is the prevalence of Anemia, Sickle Cell?
The estimated prevalence of Anemia, Sickle Cell is approximately 30.0 per 100,000 population.
Deep-dive into Anemia, Sickle Cell
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis